| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |